Report Detail
Global Irritable Bowel Syndrome Treatment Market Insights, Forecast to 2025
- RnM2692195 |
- 14 June, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.
Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period.
The global Irritable Bowel Syndrome Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Irritable Bowel Syndrome Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Irritable Bowel Syndrome Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Irritable Bowel Syndrome Treatment in these regions.
This research report categorizes the global Irritable Bowel Syndrome Treatment market by top players/brands, region, type and end user. This report also studies the global Irritable Bowel Syndrome Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Valeant Pharmaceuticals International
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
Ironwood Pharmaceuticals
GlaxoSmithKline
Allergan
Market size by Product
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Market size by End User
Hospitals
Clinics
Homecare settings
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Irritable Bowel Syndrome Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Irritable Bowel Syndrome Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Irritable Bowel Syndrome Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Irritable Bowel Syndrome Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Irritable Bowel Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Irritable Bowel Syndrome Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Irritable Bowel Syndrome Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Product
- 1.4.2 Irritable Bowel Syndrome with Constipation
- 1.4.3 Irritable Bowel Syndrome with Diarrhea
- 1.4.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
- 1.5 Market by End User
- 1.5.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Homecare settings
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Irritable Bowel Syndrome Treatment Market Size
- 2.1.1 Global Irritable Bowel Syndrome Treatment Revenue 2014-2025
- 2.1.2 Global Irritable Bowel Syndrome Treatment Sales 2014-2025
- 2.2 Irritable Bowel Syndrome Treatment Growth Rate by Regions
- 2.2.1 Global Irritable Bowel Syndrome Treatment Sales by Regions
- 2.2.2 Global Irritable Bowel Syndrome Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers
- 3.1.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers
- 3.1.2 Irritable Bowel Syndrome Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Irritable Bowel Syndrome Treatment Revenue by Manufacturers
- 3.2.1 Irritable Bowel Syndrome Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Irritable Bowel Syndrome Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Irritable Bowel Syndrome Treatment Price by Manufacturers
- 3.4 Irritable Bowel Syndrome Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Irritable Bowel Syndrome Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Irritable Bowel Syndrome Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Irritable Bowel Syndrome Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Irritable Bowel Syndrome Treatment Sales by Product
- 4.2 Global Irritable Bowel Syndrome Treatment Revenue by Product
- 4.3 Irritable Bowel Syndrome Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Irritable Bowel Syndrome Treatment Breakdown Data by End User
6 North America
- 6.1 North America Irritable Bowel Syndrome Treatment by Countries
- 6.1.1 North America Irritable Bowel Syndrome Treatment Sales by Countries
- 6.1.2 North America Irritable Bowel Syndrome Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Irritable Bowel Syndrome Treatment by Product
- 6.3 North America Irritable Bowel Syndrome Treatment by End User
7 Europe
- 7.1 Europe Irritable Bowel Syndrome Treatment by Countries
- 7.1.1 Europe Irritable Bowel Syndrome Treatment Sales by Countries
- 7.1.2 Europe Irritable Bowel Syndrome Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Irritable Bowel Syndrome Treatment by Product
- 7.3 Europe Irritable Bowel Syndrome Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Irritable Bowel Syndrome Treatment by Countries
- 8.1.1 Asia Pacific Irritable Bowel Syndrome Treatment Sales by Countries
- 8.1.2 Asia Pacific Irritable Bowel Syndrome Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Irritable Bowel Syndrome Treatment by Product
- 8.3 Asia Pacific Irritable Bowel Syndrome Treatment by End User
9 Central & South America
- 9.1 Central & South America Irritable Bowel Syndrome Treatment by Countries
- 9.1.1 Central & South America Irritable Bowel Syndrome Treatment Sales by Countries
- 9.1.2 Central & South America Irritable Bowel Syndrome Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Irritable Bowel Syndrome Treatment by Product
- 9.3 Central & South America Irritable Bowel Syndrome Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Irritable Bowel Syndrome Treatment by Countries
- 10.1.1 Middle East and Africa Irritable Bowel Syndrome Treatment Sales by Countries
- 10.1.2 Middle East and Africa Irritable Bowel Syndrome Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Irritable Bowel Syndrome Treatment by Product
- 10.3 Middle East and Africa Irritable Bowel Syndrome Treatment by End User
11 Company Profiles
- 11.1 Valeant Pharmaceuticals International
- 11.1.1 Valeant Pharmaceuticals International Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Valeant Pharmaceuticals International Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Valeant Pharmaceuticals International Irritable Bowel Syndrome Treatment Products Offered
- 11.1.5 Valeant Pharmaceuticals International Recent Development
- 11.2 Sucampo Pharmaceuticals
- 11.2.1 Sucampo Pharmaceuticals Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
- 11.2.5 Sucampo Pharmaceuticals Recent Development
- 11.3 Abbott Laboratories
- 11.3.1 Abbott Laboratories Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Abbott Laboratories Irritable Bowel Syndrome Treatment Products Offered
- 11.3.5 Abbott Laboratories Recent Development
- 11.4 Lexicon Pharmaceuticals
- 11.4.1 Lexicon Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
- 11.4.5 Lexicon Pharmaceuticals Recent Development
- 11.5 Salix Pharmaceuticals
- 11.5.1 Salix Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
- 11.5.5 Salix Pharmaceuticals Recent Development
- 11.6 Ironwood Pharmaceuticals
- 11.6.1 Ironwood Pharmaceuticals Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Products Offered
- 11.6.5 Ironwood Pharmaceuticals Recent Development
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline Irritable Bowel Syndrome Treatment Products Offered
- 11.7.5 GlaxoSmithKline Recent Development
- 11.8 Allergan
- 11.8.1 Allergan Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Allergan Irritable Bowel Syndrome Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Allergan Irritable Bowel Syndrome Treatment Products Offered
- 11.8.5 Allergan Recent Development
12 Future Forecast
- 12.1 Irritable Bowel Syndrome Treatment Market Forecast by Regions
- 12.1.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Irritable Bowel Syndrome Treatment Market Forecast by Product
- 12.2.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Product 2019-2025
- 12.3 Irritable Bowel Syndrome Treatment Market Forecast by End User
- 12.4 North America Irritable Bowel Syndrome Treatment Forecast
- 12.5 Europe Irritable Bowel Syndrome Treatment Forecast
- 12.6 Asia Pacific Irritable Bowel Syndrome Treatment Forecast
- 12.7 Central & South America Irritable Bowel Syndrome Treatment Forecast
- 12.8 Middle East and Africa Irritable Bowel Syndrome Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Irritable Bowel Syndrome Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome Treatment . Industry analysis & Market Report on Irritable Bowel Syndrome Treatment is a syndicated market report, published as Global Irritable Bowel Syndrome Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
